Skip to main content
Steven Lubitz, MD, Cardiology, Boston, MA

Steven Alan Lubitz MD

Cardiac Electrophysiology


Massachusetts General Hospital

Join to View Full Profile
  • 55 Fruit StreetGrb 109Boston, MA 02114

  • Phone+1 617-726-2000

Dr. Lubitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2010 - 2012
  • Harvard School of Public Health
    Harvard School of Public HealthMPH, 2008 - 2010
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2006 - 2009
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2002 - 2006
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2002

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2026
  • NY State Medical License
    NY State Medical License 2003 - 2008
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Clinical Cardiac Electrophysiology
    American Board of Internal Medicine Clinical Cardiac Electrophysiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genome-Wide Polygenic Scores for Common Diseases Identify Individuals with Risk Equivalent to Monogenic Mutations  
    Amit V Khera, Steven A Lubitz, Sekar Kathiresan, Patrick T Ellinor, Krishna G Aragam, Pradeep Natarajan, Nature

Press Mentions

  • Wearable Devices Are Cost-Effective AF Screening Tools
    Wearable Devices Are Cost-Effective AF Screening ToolsAugust 10th, 2022
  • Wearable Tech Increasingly Discussed by Primary Care Patients, Doctors
    Wearable Tech Increasingly Discussed by Primary Care Patients, DoctorsJuly 1st, 2022
  • Fitbit’s Latest AFib Algorithm Receives FDA Clearance, Will Be Available ‘Soon’
    Fitbit’s Latest AFib Algorithm Receives FDA Clearance, Will Be Available ‘Soon’April 12th, 2022
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: